Alymsys (bevacizumab-maly) is an anti-angiogenic therapy used to block the blood supply that feeds cancer tumors and prevents it from growing. This is different from chemotherapy, which attacks the cancer cells themselves. Alymsys is a biosimilar medication. To learn more about biosimilars click the button below.
PATHways provides you with a straight-forward range of resources and services designed to easily map your personal path toward more accessible medication. Learn what is available to you and how to keep things moving along your individual treatment path.